Alaunos Therapeutics
Organisation
Trials
Phase 3Terminated2010447 people23 Jul 2010clinicaltrials.gov
Phase 2Terminated200867 people18 Jul 2008clinicaltrials.gov
Phase 1Completed200830 people6 Feb 2008clinicaltrials.gov
Organisation
Phase 3Terminated2010447 people23 Jul 2010clinicaltrials.gov
Phase 2Terminated200867 people18 Jul 2008clinicaltrials.gov
Phase 1Completed200830 people6 Feb 2008clinicaltrials.gov